Atea
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (32)
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
Started: 6/2/2025
C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV
Started: 4/7/2025
SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19
Started: 11/25/2022
A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV
Started: 5/30/2023
Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) in a Hospital Setting
Started: 5/26/2020
Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) Infection
Started: 6/20/2019
Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic Function
Started: 4/9/2025
Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone
Started: 1/7/2025
Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)
Started: 12/4/2025
Drug-drug Interaction Study of Omeprazole and Bemnifosbuvir/Ruzasvir
Started: 5/9/2025
Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Digoxin and Rosuvastatin
Started: 4/8/2025
Pharmacokinetics of Fixed-Dose Combination Tablet of Bemnifosbuvir and Ruzasvir
Started: 12/14/2023
Drug-drug Interaction Study of Biktarvy and Bemnifosbuvir/Ruzasvir
Started: 4/15/2024
Study of AT-527 in Subjects With Normal and Impaired Renal Function
Started: 10/17/2022
Study of Bemnifosbuvir in Subjects With Normal and Impaired Hepatic Function
Started: 1/30/2023
The Study of Bemnifosbuvir in Healthy Japanese Subjects
Started: 4/26/2023
Study of Bemnifosbuvir on Cardiac Repolarization in Healthy Subjects
Started: 4/25/2023
Drug-drug Interaction Study of Ruzasvir and Bemnifosbuvir
Started: 1/30/2023
Study of AT-752 in Healthy Subjects in a Dengue Human Challenge Model
Started: 4/22/2022
Study of AT-527 in Healthy Subjects Under Fasting Conditions or With a Meal
Started: 2/22/2022
Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects
Started: 10/1/2021
Drug-drug Interaction Study of Digoxin and AT-527 (R07496998)
Started: 11/3/2021
Drug-drug Interaction Study of Rosuvastatin and AT-527 (R07496998)
Started: 11/16/2021
Mass Balance Study of AT-527 in Healthy Adult Male Subjects (R07496998)
Started: 7/28/2021
Effect of Cyclosporine on the Pharmacokinetics (PK) of AT-527 (R07496998)
Started: 4/18/2021
Effect of Carbamazepine on the Pharmacokinetics (PK) of AT-527
Started: 3/1/2021
Drug-drug Interaction Study of Midazolam and AT-527 (R07496998)
Started: 4/22/2021
Study of AT-527 in Healthy and HCV-Infected Subjects
Started: 7/6/2017